$Revolution Medicines(RVMD.US)$rose more than 10% Wednesday after the biotech firm reported the discovery and preclinical-to-clinical translation of its anti-tumor drug RMC-6236. RVMD gained 10.6% to close at $36.50 on word of the experimental drug, which the company disclosed in the publication Cancer Discovery. Revolution disclosed news of the drug on Tuesday shortly before the market closed, sending shares up 3.4% that da...
Focus Financial Downgraded to Market Perform From Outperform at William Blair William Blair analyst Jeff Schmitt downgraded$Focus Financial Partners(FOCS.US)$to Market Perform from Outperform after the company reached an agreement to be acquired by Clayton, Dubilier & Rice and Stone Point Capital in an all-cash transaction valued at $53 in cash per share. Credit Suisse Upgrades Celsius Holdings to Outperform, Raises Price Target to $...
Gainers: In reaction to earnings/guidance: •$宏盟集团(OMC.US)$+6.8% (Omnicom reports Q2 EPS $1.68, consensus $1.58) •$奈飞(NFLX.US)$+6.3% (Netflix executives said they expect 1 million new subscribers to join in the third quarter, with revenue forecast to grow to $7.84 billion from $7.48 billion a year ago) •$富尔顿金融(FULT.US)$+4.3% (Fulton Financial reports Q2 EPS 42c, consensus 37c) •$雅培(ABT.US)$+0.6% (Ab...
Revolution Medicines股票讨论区
专栏Revolution Medicines Gains 10%+ on Word of Experimental Anti-Tumor Drug
RVMD gained 10.6% to close at $36.50 on word of the experimental drug, which the company disclosed in the publication Cancer Discovery.
Revolution disclosed news of the drug on Tuesday shortly before the market closed, sending shares up 3.4% that da...
Someone just sold 25000 shares. How good they are in timing.
still right ✅️ rising
going up
Sheesh 😮💨
easy 1.00 squeeze
👀👀 breaking out
专栏US Top Rating Updates on 2/28: DKS, CELH, FOCS, TCOM and More
William Blair analyst Jeff Schmitt downgraded $Focus Financial Partners(FOCS.US)$ to Market Perform from Outperform after the company reached an agreement to be acquired by Clayton, Dubilier & Rice and Stone Point Capital in an all-cash transaction valued at $53 in cash per share.
Credit Suisse Upgrades Celsius Holdings to Outperform, Raises Price Target to $...
专栏Today's pre-market stock movers: NFLX, NVAX, ASML, BBWI and more
In reaction to earnings/guidance:
• $宏盟集团(OMC.US)$ +6.8% (Omnicom reports Q2 EPS $1.68, consensus $1.58)
• $奈飞(NFLX.US)$+6.3% (Netflix executives said they expect 1 million new subscribers to join in the third quarter, with revenue forecast to grow to $7.84 billion from $7.48 billion a year ago)
• $富尔顿金融(FULT.US)$ +4.3% (Fulton Financial reports Q2 EPS 42c, consensus 37c)
• $雅培(ABT.US)$ +0.6% (Ab...
暂无评论